Flucelvax Tetra

Flucelvax Tetra is a quadrivalent influenza vaccine designed to protect against four strains of the flu virus. This vaccine is suitable for adults and is administered intramuscularly. It is manufactured by Seqirus Netherlands B.V. and is available in the EU.

Flucelvax Tetra is used to prevent influenza caused by the four strains of the virus included in the vaccine. It is typically administered annually to provide immunity against seasonal flu. This vaccine is particularly important for individuals who are at higher risk of complications from influenza, such as the elderly or those with chronic health conditions.

Common effects of Flucelvax Tetra may include mild soreness, redness, or swelling at the injection site. Some individuals may experience mild fever, fatigue, or muscle aches following vaccination. These effects are usually temporary and resolve within a few days.

Flucelvax Tetra should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to previous influenza vaccines or any components of this vaccine should consult their healthcare provider before receiving it. It is important to inform your healthcare provider about any current medications or health conditions before vaccination.

Flucelvax Tetra may interact with certain medications or health conditions. It is important to discuss any current medications, including over-the-counter drugs and supplements, with your healthcare provider before receiving the vaccine. Additionally, individuals with weakened immune systems should consult their healthcare provider regarding the appropriate timing of vaccination.